Umbilical cord blood-derived natural killer (NK) cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Umbilical cord blood-derived natural killer (NK) cell therapy, covering 2025-02-27 to 2025-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study [NA]